Healthcare Value Capital as of Dec. 31, 2012
Portfolio Holdings for Healthcare Value Capital
Healthcare Value Capital holds 31 positions in its portfolio as reported in the December 2012 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Forest Laboratories | 11.8 | $12M | 326k | 35.32 | |
| AstraZeneca (AZN) | 9.0 | $8.7M | 185k | 47.27 | |
| St. Jude Medical | 7.1 | $6.9M | 192k | 36.14 | |
| Sanofi-Aventis SA (SNY) | 5.8 | $5.7M | 120k | 47.38 | |
| Merck & Co (MRK) | 5.1 | $5.0M | 122k | 40.94 | |
| Pfizer (PFE) | 4.8 | $4.6M | 184k | 25.08 | |
| WellCare Health Plans | 4.5 | $4.4M | 90k | 48.70 | |
| GlaxoSmithKline | 4.2 | $4.1M | 95k | 43.47 | |
| Obagi Medical Products | 3.8 | $3.7M | 272k | 13.59 | |
| Qlt | 3.8 | $3.7M | 469k | 7.86 | |
| Boston Scientific Corporation (BSX) | 3.5 | $3.4M | 589k | 5.73 | |
| Cardinal Health (CAH) | 3.5 | $3.4M | 82k | 41.18 | |
| Omnicare | 3.4 | $3.3M | 92k | 36.10 | |
| Baxter International (BAX) | 2.8 | $2.7M | 40k | 66.65 | |
| Zimmer Holdings (ZBH) | 2.8 | $2.7M | 40k | 66.65 | |
| Sagent Pharmaceuticals | 2.6 | $2.5M | 156k | 16.09 | |
| Express Scripts Holding | 2.5 | $2.4M | 45k | 54.00 | |
| CryoLife (AORT) | 2.4 | $2.3M | 375k | 6.23 | |
| Humana (HUM) | 2.3 | $2.2M | 33k | 68.62 | |
| Hospira | 2.2 | $2.2M | 70k | 31.25 | |
| Supernus Pharmaceuticals (SUPN) | 2.1 | $2.0M | 285k | 7.17 | |
| Auxilium Pharmaceuticals | 1.9 | $1.9M | 101k | 18.54 | |
| Cornerstone Therapeutics | 1.8 | $1.7M | 369k | 4.73 | |
| NuVasive | 1.5 | $1.5M | 97k | 15.46 | |
| Walgreen Company | 1.1 | $1.1M | 30k | 37.00 | |
| Impax Laboratories | 1.1 | $1.0M | 50k | 20.50 | |
| Vivus | 0.7 | $671k | 50k | 13.42 | |
| Sunesis Pharmaceuticals | 0.7 | $669k | 159k | 4.20 | |
| Allscripts Healthcare Solutions (MDRX) | 0.5 | $471k | 50k | 9.42 | |
| PROLOR Biotech | 0.3 | $282k | 57k | 4.95 | |
| Zogenix | 0.3 | $275k | 207k | 1.33 |
